PPCB (PPCB) Stock Price, News & Analysis

Company Overview

Propanc Biopharma, Inc. is a healthcare company. It focuses on the development of cancer treatments for pancreatic, ovarian and colorectal cancer primarily in Australia. The Company's products include PRP and PRP-DCM. Propanc Biopharma, Inc., formerly known as Propanc Health Group Corporation, is based in Camberwell, Australia.

Key Stats

• Today's Range: $0.09 to $0.10
• 50-Day Range: $0.09 to $0.20
• 52-Week Range: $0.09 to $10.81
• Volume: 432,373 shs
• Average Volume: 6.65 million shs
• Market Capitalization: $1.47 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

PPCB Stock Analysis - MarketRank™

PPCB scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

PPCB has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

PPCB has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.7 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of PPCB is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

PPCB has a P/B Ratio of 0.08. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for PPCB.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PPCB does not currently pay a dividend.

Dividend Growth

PPCB does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for PPCB on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, PPCB insiders have not sold or bought any company stock.

Percentage Held by Insiders

28.50% of the stock of PPCB is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

PPCB has minimal institutional ownership at this time.

PPCB Stock Analysis - Frequently Asked Questions

How have PPCB shares performed this year?

PPCB's stock was trading at $0.3513 at the start of the year. Since then, PPCB stock has decreased by 73.5% and is now trading at $0.0930.

How were PPCB's earnings last quarter?

PPCB (NASDAQ:PPCB) posted its quarterly earnings results on Tuesday, February, 17th. The company reported ($0.30) earnings per share (EPS) for the quarter.

When did PPCB IPO?

PPCB (PPCB) raised $5 million in an initial public offering on Friday, August 15th 2025. The company issued 1,000,000 shares at $4.00-$6.00 per share. D. Boral Capital (ex-EF Hutton) and Craft Capital served as the underwriters for the IPO.

How do I buy shares of PPCB?

Shares of PPCB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 2/17/2026
• Today: 5/07/2026
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:PPCB
• CIK: 1517681
• Web: www.propanc.com
• Phone: 61-03-9882-0780
• Fax: 61 03 9882 9969
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($13.19)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$58.92 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -465.18%
• Return on Assets: -351.21%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.13
• Quick Ratio: 2.13

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.20 per share
• Price / Book: 0.08

Miscellaneous

• Outstanding Shares: 15,860,000
• Free Float: 11,339,000
• Market Cap: $1.47 million
• Optionable: N/A
• Beta: 3.59